Rucha Patil Reflects on 49th MHG Annual Conference and Essence of ASH 2025
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”The 49th Annual Conference of the Mumbai Hematology Group (MHG) 2026 and Essence of ASH 2025, held from 24th–26th January 2026 at Bombay Hospital, Mumbai, was truly an enriching and memorable experience.
An outstanding scientific program featuring eminent international and national speakers, dedicated faculty, and enthusiastic delegates—along with exceptional participation from across India in award orals and poster presentations—made this conference truly special.
Beyond the science, the conference offered invaluable opportunities for networking, reconnecting with colleagues, and sharing moments with friends and loved ones, making the experience even more meaningful.
I am deeply honored to serve as Secretary of MHG and to have had the privilege of conducting both the Inaugural and Valedictory sessions.
It was especially meaningful to speak on a topic close to my heart—Health Technology Assessment (HTA) for drugs, focusing on Emicizumab and Extended Half-Life (EHL) therapies in hemophilia, undertaken in collaboration with NHM, DHR, and ICMR.
Closing the conference by recognizing award winners and expressing gratitude to everyone who contributed was the perfect conclusion to an exceptional meeting.
An absolutely fantastic conference—made possible by teamwork, science, and shared connections.
And now, the countdown begins!
MHG turns 50—golden and fabulous
22–24 January 2027 | Golden Jubilee Conference
Save the dates!”
Stay updated with Hemostasis Today.
-
Mar 20, 2026, 17:47Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
-
Mar 20, 2026, 17:45William Tembo: Advancing Stroke Care by Validating Acute Ischemic Treatment
-
Mar 20, 2026, 17:37Renjith Vijayakumar Selvarani: New Nanoparticle Approach Clears Brain Plaque and Restores Memory
-
Mar 20, 2026, 17:35Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
-
Mar 20, 2026, 17:17Angelo Cascio Rizzo: CTA-Based Plaque RADS Improves Risk Stratification in ESUS
-
Mar 20, 2026, 17:09Clinical Practice Guidelines for Platelet Transfusion in Non-Surgical and Non-Traumatic Settings – CEBaP
-
Mar 20, 2026, 17:07The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH
-
Mar 20, 2026, 17:05Pierre Fontana: Launching the European Interuniversity Certificate in Clinical Haemostasis
-
Mar 20, 2026, 16:49Wolfgang Miesbach: A Pivotal Step Forward for Patients with von Willebrand Disease Across All Subtypes